[HTML][HTML] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - hero.epa.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[PDF][PDF] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - pdfs.semanticscholar.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[PDF][PDF] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - Citeseer
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - europepmc.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
[HTML][HTML] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - oncotarget.com
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and
prostate cancer metastatic spread | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget …
prostate cancer metastatic spread | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget …
[引用][C] Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - cir.nii.ac.jp
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and
prostate cancer metastatic spread | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
prostate cancer metastatic spread | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
E Giannoni, ML Taddei, A Morandi, G Comito… - ONCOTARGET, 2015 - flore.unifi.it
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
E Giannoni, ML Taddei, A Morandi, G Comito… - Oncotarget, 2015 - europepmc.org
Cancer associated fibroblasts (CAFs) are key determinants of cancer progression. In
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …
prostate carcinoma (PCa), CAFs induce epithelial-mesenchymal transition (EMT) and …